Redefining health in the renal population (screening)
Join us for a screening of a recent seminar on quality of life, patient values and lessons from the ACTIVE dialysis trial delivered by Meg Jardine and Brendan Smyth at The George Institute for Global Health, Sydney. In their presentation, Meg and Brendan discuss whether, and how, quality of life can be measured reliably and meaningfully during trials. They specifically focus on whether changing dialysis methods impacts the quality of life of the study renal population versus the ‘normal’ population.
The screening runs for 50 minutes. Please get in touch if you would like further information.